ALTB-168
AltruBio
[' uc ']
at this year s , dr. david rubin ( ) is presenting proof of concept data using a novel ai-powered method to analyze patient tissue from altrubio s phase 2b study of altb-168. read our full press release here: #ddw2023 #gitwitter 
AltruBio is developing first-in-class #ImmuneModulators targeting diseases in #immunology and #inflammation with world class experts in #drugdevelopment